Hepatitis B and C in HIV-infected patients: Prevalence and prognostic value

Journal of Hepatology

Volumn 27, Issue 1, 1997, Pages 18-24

  Ockenga, Johann ^a   Tillmann, Hans Ludger ^a   Trautwein, Christian ^a   Stoll, Matthias ^a   Manns, Michael Peter ^a   Schmidt, Reinhold Ernst ^a  

^a NONE

Author keywords

Hepatitis; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Prognosis; Replication

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHOLINESTERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL; VIRUS REPLICATION;

EID: 0030795953     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80274-7     Document Type: Article

References (41)

1. McNair AN, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis. 12:1992;188-196.
2. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology. 20:1994;1152-1155.
3. Quaranta JF, Delaney SR, Alleman S, Cassuto JP, Dellamonica P, Allain JP. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (NICE SEROCO Cohort). J Med Virol. 33:1994;177-180.
4. Dorruci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis. 172:1992;1503-1508.
5. Scharschmidt BF, Held MJ, Hollander HH, Read AE, Lavine JE, Veereman G, et al. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med. 117:1992;837-838.
6. Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, Buchbinder S, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis. 163:1991;454-459.
7. Degos F, Lugassy C, Degott C, Debure A, Carnot F, Thiers V, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients. Gastroenterology. 94:1988;151-156.
8. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus, hepatitis delta virus and hepatitis B virus infection in 260 chronic carrier of hepatitis B virus. Hepatology. 15:1992;578-583.
9. Twu J, Chu K, Robinson W. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Acad Sci USA. 86:1989;5168-5172.
10. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis. 18:1994;339-347.
11. Gitnick G. Hepatitis infection in immunocompromised patients. Gastroenterol Clin North Am. 23:1994;515-521.
12. Martin P, Di Biscegli AM, Kassianides C, Lisker-Melmann M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 97:1989;1559-1561.
13. Soriano V, Garcia Samaniego J, Bravo R, Valencia E, Laguna F, de Pouplana M, et al. Morbidity and mortality associated with chronic viral hepatopathy in patients infected with the human immunodeficiency virus. Med Clin Barc. 104:1995;641-644.
14. Eskild A, Magnus P, Petersen G, Sohlberg C, Jensen F, Kittelsen P, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS. 6:1992;571-574.
15. Park RAA. European AIDS definition. Lancet. 339:1992;671.
16. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology. 106:1994;1603-1610.
17. Hoffmeyer F, Witte K, Gebhardt U, Schmidt RE. The low affinity Fc gamma RIIa and Fc gamma RIIIb on polymorphonuclear neutrophils are differentially regulated by CD45 phosphatase. J Immunol. 155:1995;4016-4023.
18. Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol. 90:1995;1250-1257.
19. Diamondsstone LS, Blakley SA, Rice JC, Clark RA, Goedert JJ. Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. Am J Epidemiol. 142:1995;304-313.
20. Tamm A, Kister A, Nolte K, Gessner J, Schmidt RE. The IgG binding site of human Fc-gamma RIIIB receptor involves CC and FG loops of the membrane-proximal domain. J Biol Chem. 271:1996;3659-3666.
21. Naoumov NV, Eddleston AL. Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut. 35:1994;1013-1017.
22. Tillmann HL, Trautwein C, Walker D, Michitaka K, Kubicka S, Böker KHW, et al. Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut. 37:1995;568-573.
23. Koziel M, Dudley D, Wong J, Dienstag J, Houghton M, Ralston R, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1996;3339-3344.
24. J Lau, Davis G, Kniffen J, Qian K, Urdea M, Chan C, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
25. Eyster M, Fried M, Bisceglie A, Goedert J. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood. 84:1994;1020-1023.
26. Telfer PT, Brown D, Devereux H, Lee CA, DuSheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol. 88:1994;397-399.
27. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol. 87:1994;555-561.
28. Stanley SK, Ostrowski MA, Justement JS, Gant K, Hedayati S, Mannix M, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med. 334:1996;1222-1230.
29. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 333:1995;751-756.
30. Süttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Müller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr. 8:1995;239-246.
31. Müller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz U, et al. Mechanism of insulin resistance associated with liver cirrhosis. Impact of the aetiology of cirrhosis, the clinical and the nutritional state of the patients. Gastroenterology. 102:1992;2033-2041.
32. Trautwein C, Boker KHW, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut. 35:1994;1163-1166.
33. Ockenga J, Rohde F, Süttmann U, Herbarth L, Ballmaier M, Schedel I. Ketotifen in HIV-infected patients: effects on body weight and release of tumor necrosis factor alpha. Eur J Clin Pharmacol. 50:1996;167-170.
34. Benhamou Y, Dohin E, Lunel Fabiani F, Poynard T, Huraux JM, Katlama C, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. (letter). Lancet. 345:1995;396-397.
35. Lundgren JD, Pedersen C, Clumeck N, Gatell JM, Johnson AM, Ledergerber B, et al. Survival differences in European patients with AIDS, 1979-89. Br Med J. 308:1994;1068-1073.
36. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA. 271:1994;1083-1087.
37. Maschek H, Georgii A, Schmidt RE, Kirschner P, Böttger E. Mycobacterium genavense. Autopsy findings in three patients. Am J Clin Pathol. 101:1994;95-99.
38. Iwarson S, Jilg W, Stroffolini T. Substantial decline of notified hepatitis B in major parts of Europe after 1985. Scand J Infect Dis. 26:1994;19-22.
39. Sharara AI, Hunt CM, Hamilton D. Hepatitis C. Ann Intern Med. 125:1996;658-668.
40. Boyer N. Recombinant interferon-alpha for chronic hepatitis inpatients positive for antibody to human immunodeficiency virus. J Infect Dis. 165:1992;723-726.
41. Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, et al. Interferon alpha treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. Gastroenterology. 108:1995;165-171.